A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy

Abstract Mutated oncogenic Kirsten rat sarcoma virus (KRAS) antigen is expressed in a large variety of cancers, including pancreatic, colorectal, and pulmonary cancers. The oncogenic KRAS mutations cause malignancies and are usually ubiquitously expressed by all cells of a tumor. The KRAS amino acid...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Anastasia Goloudina, Fabien Le Chevalier, Pierre Authié, Sylvain Ciret, Kirill Nemirov, Ingrid Fert, Fanny Moncoq, Benjamin Vesin, Amandine Noirat, Catherine Blanc, Yu Wei, Pierre Charneau, Laleh Majlessi
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2025-07-01
סדרה:	Scientific Reports
נושאים:	Cancer immunotherapy Inhibition of tumor growth KRAS oncogenic mutations KRASG12D Lentiviral vectors
גישה מקוונת:	https://doi.org/10.1038/s41598-025-05134-6
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!